drugset / Trial / NCT00145886
rhPTH Therapy for Low Turnover Bone Fragility
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine how treatment with a new medication, recombinant human parathyroid hormone (rhPTH) affects calcium balance and bone strength.
Timeline
- Start
- 2003-02
- Primary completion
- 2011-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Teriparatide | Protein / enzyme biologic | — | — |